Cargando…
The PI3K/Akt pathway: a critical player in intervertebral disc degeneration
Intervertebral disc degeneration (IDD) is thought to be the primary cause of low back pain, a severe public health problem worldwide. Current therapy for IDD aims to alleviate the symptoms and does not target the underlying pathological alternations within the disc. Activation of the phosphatidylino...
Autores principales: | Ouyang, Zhi-Hua, Wang, Wen-Jun, Yan, Yi-Guo, Wang, Bing, Lv, Guo-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593690/ https://www.ncbi.nlm.nih.gov/pubmed/28915718 http://dx.doi.org/10.18632/oncotarget.18628 |
Ejemplares similares
-
lncRNAs: novel players in intervertebral disc degeneration and osteoarthritis
por: Chen, Wen‐Kang, et al.
Publicado: (2016) -
Dihydroartemisinin Attenuated Intervertebral Disc Degeneration via Inhibiting PI3K/AKT and NF-κB Signaling Pathways
por: Liao, Zhiheng, et al.
Publicado: (2022) -
Upregulation of SIRT1 by Evodiamine activates PI3K/AKT pathway and blocks intervertebral disc degeneration
por: Kuai, Jianbo, et al.
Publicado: (2022) -
Treatment of Intervertebral Disc Degeneration
por: Xin, Jingguo, et al.
Publicado: (2022) -
Circ0007042 alleviates intervertebral disc degeneration by adsorbing miR-369 to upregulate BMP2 and activate the PI3K/AKt pathway
por: Wang, Zhenyu, et al.
Publicado: (2022)